To support compliance, the government revised Schedule M of the Drugs and Cosmetics Rules, 1945, in 2023, outlining phased ...
Windlas Biotech's new GMP-certified injectable facility expands manufacturing capabilities for global pharmaceutical markets.
HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“ HYTN ” or the “Company ”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce ...
New Delhi: The Centre plans to extend the deadline for complying with good manufacturing practice (GMP), at par with the World Health Organization (WHO) standards, for small pharmaceutical compani ...
Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority ...